Neurovascular Thrombus Procedures

Showing all 5 results

Neurology Devices Market Analysis, Size, Trends | United States | 2020-2026 | MedSuite

In 2020, the U.S. neurology devices market size was valued at $4.8 billion, and there were over 726,000 neurological procedures performed. The market size is expected to increase at a growth rate of 6.9% to reach $7.6 billion in 2026. Throughout this medical market research, we analyzed 44 neurological device companies across the United States


Neurological Devices Market Analysis, Size, Trends | Europe | 2019-2025 | MedSuite (Includes 14 Reports)

The full report suite on the European market for neurological devices includes cerebrospinal fluid management devices, detachable coils, liquid embolics, neurovascular guidewires, neurovascular catheters, neurovascular stents, aneurysm clips, intrasaccular stents, neurovascular thrombectomy devices, ultrasonic aspirators, neuromodulation devices, intrathecal pumps, stereotactic devices and transcranial magnetic simulators. The market for balloon occlusion is discussed separately in the


Neurovascular Devices Market Analysis, Size, Trends | Global | 2017-2023 | MedCore

Industry Trends The neurovascular devices market includes three market segments: neurovascular catheters, neurovascular guidewires, and neurovascular stents. Neurovascular catheters, also known as microcatheters, are a type of catheter small enough to be used in neurovascular procedures. Microcatheters are designed with several properties in mind: hydrophilic coating, softness, trackability and stability. Of the devices in this


Mechanical Thrombectomy Market Analysis | Europe | 2019-2025 | MedCore

Ischemic Stroke is caused by an obstruction within a blood vessel that is supplying blood to the brain. This is often caused by blood clots but can also be caused by other substances like plaques. The gold standard treatment for strokes for many years has been the administration of clot dissolving or clot busting medication called tissue plasminogen activator (tPA). This type of drug must be administered as soon as possible, with a four hour window from symptom onset, to increase chances of recovery. A significant number of patients do not get to healthcare facilities quickly enough to meet that window and even some of those who do, later experience hemorrhagic complications from the medication. It is very effective for smaller clots but often fails to break up larger clots. Some patients cannot receive tPA, in which cases physicians rely on antiplatelet or anticoagulant medicine to ensure blood clots do not get larger.


Neuromodulation, Neurovascular, Neurosurgical and Monitoring Devices Procedure Volume Analysis | United States | 2020-2026 | MedPro

This report analyzes the procedure volumes for neurological device markets in the US between 2013 and 2023. Segmentation includes 8 main segments: Cerebrospinal Fluid Shunting Procedures, Lumbar Shunting Procedures, Neurovascular Embolization Procedures, Neuromodulation Procedures, Spinal Cord Stimulator Procedures, Deep Brain Stimulator Procedures, Peripheral Nerve Stimulator Procedures, Vagus, Sacral and Gastric Nerve Stimulator Implementation Procedures, Aneurysm Clipping Procedures, Intrathecal Pump Procedures and Intracranial Neuroendoscopic Procedures